Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Author: Jingjiao Li

Link to paper:

Journal/ Pre-Print: BioRxiv

Key Words: Proteomics, Interactome, neutrophils, cytokine storm

Research Highlights

1. Elucidation of SARS-Cov-2 intra-viral and host-virus protein-protein interactions (PPI)

2. Proteomic profiling of PBMCs from COVID-19 patients with mild and severe disease

3. Identification of NKRF-nsp9 as a possible drug target and IL8/IL6 antagonists as drugs that could be repurposed for COVID19 treatment


The study investigates the viral-viral and viral-host protein interactome with genome-wide co-immunoprecipitation (in HEK293T) and yeast-two hybrid screens. Intra-viral PPI network suggest targets for small molecules or peptide drugs against specific epitopes. Host-viral PPI uncovered potential host targets, e.g. nsp9-NKRF facilitates IL-8/IL-6 production, possibly facilitating lung cytokine storm. The proteomic profile of PBMCs from COVID-19 patients examined and revealed an upregulation of innate immune responses (especially neutrophils) in mild cases compared to healthy controls and a functional decline in adaptive immunity in severe compared to mild cases. Only summary figures, not full results, were available at the time of writing.

Impact for SARS-CoV2/COVID19 research efforts

Understand the immune response to SARS-CoV2/COVID19

Understand the virology and/or cell biology of SARS-CoV2/COVID19

Identification of new targets for treatment of SARS-CoV2/COVID19 positive individuals

Study Type

· In vitro study

· Clinical Cohort study (e.g. drug trials)

· Genome wide

· Proteomics

Strengths and limitations of the paper

Novelty: Proteomics of PBMCs from infected patients. NKRF as possible drug target. Intra-viral and host-virus full genome interactome

Standing in the field: It recapitulates data that indicate neutrophils are very abundant in initial COVID-19 followed by lymphopenia in more severe cases and reiterates that IL6 may be an important cytokine in the disease pathogenesis. It gives a possible explanation for excessive neutrophil infiltration in the lung and subsequent cytokine storm.

Appropriate statistics: yes where shown

Viral model used: SARS-CoV-2 Wuhan-Hu-1 isolate (for protein prediction)

Translatability: NKRF on patients as possible target to stop upregulation of IL-8/IL-6 and avoid excessive neutrophil migration into the lung and subsequent cytokine storm.

Main limitations: PPI studied in HEK293 cells (not the cells targeted by the virus). Different screening methods (Co-IP vs Y2H) give different results. Supplementary material not shown (only interactome map shown for most experiments). Small sample size for human PBMCs (surprisingly, the number of control PBMC samples is particularly low).